Shopping Cart
- Remove All
Your shopping cart is currently empty
FLT3-IN-10 (2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-) (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 2 mg | $32 | In Stock | |
| 5 mg | $54 | In Stock | |
| 10 mg | $93 | In Stock | |
| 25 mg | $191 | In Stock | |
| 50 mg | $282 | In Stock | |
| 100 mg | $401 | In Stock | |
| 200 mg | $545 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $52 | In Stock |
| Description | FLT3-IN-10 (2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-) (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML). |
| Synonyms | 2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl- |
| Molecular Weight | 254.26 |
| Formula | C15H11FN2O |
| Cas No. | 2088735-51-5 |
| Smiles | Fc1ccc(cc1)-c1cnc(Nc2ccccc2)o1 |
| Relative Density. | 1.265 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (216.31 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.